SONO

COM:SONOMABIO

Sonoma Biotherapeutics

  • Privately Held

Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system.

peer of

investor of

competitor of